Back
Perspective Therapeutics Stock Price Chart
Is the Traditional House Obsolete?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.
Sell
46
CATX
Perspective Therapeutics
Last Price:
$2.5600
Seasonality Move:
0.94%
7 Day Trial
ALL ACCESS PASS
$
7
Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.-
The current trend is moderately bullish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
Perspective Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.54 | Sell |
| 20-day SMA: | 2.46 | Sell |
| 50-day SMA: | 2.29 | Buy |
| 200-day SMA: | 6.7 | Sell |
| 8-day EMA: | 2.55 | Sell |
| 20-day EMA: | 2.44 | Buy |
| 50-day EMA: | 2.5 | Sell |
| 200-day EMA: | 5.29 | Sell |
Perspective Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 51.2 | Buy |
| Chaikin Money Flow: | -694728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.1464 - 2.6064) | Buy |
| Bollinger Bands (100): | (2.1734 - 3.2934) | Sell |
Perspective Therapeutics Technical Analysis
| May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Perspective Therapeutics Stock
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.4600 while CATX 8-day simple moving average is 2.5350, which is a Sell signal.
-
The stock price of CATX is 2.4600 while Perspective Therapeutics 20-day SMA is 2.4615, which makes it a Sell.
-
Perspective Therapeutics 50-day simple moving average is 2.2944 while CATX share price is 2.4600, making it a Buy technically.
-
CATX stock price is 2.4600 and Perspective Therapeutics 200-day simple moving average is 6.7046, creating a Sell signal.
CATX Technical Analysis vs Fundamental Analysis
Sell
46
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy or a Sell?
-
Perspective Therapeutics stock is rated a SellThe current Perspective Therapeutics [CATX] share price is $2.4600. The Score for CATX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Perspective Therapeutics Stock Info
Market Cap:
182.6M
Price in USD:
2.4600
Share Volume:
731.3K
Perspective Therapeutics 52-Week Range
52-Week High:
16.7000
52-Week Low:
1.6000
Sell
46
Perspective Therapeutics (CATX)
is a Sell
Perspective Therapeutics Share Price Forecast
-
What is the Perspective Therapeutics stock price today?The Perspective Therapeutics stock price is 2.4600 USD today.
-
Will CATX stock go up or go down?Perspective Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Perspective Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Perspective Therapeutics is overvalued.
Is Perspective Therapeutics Stock a Buy?
-
Perspective Therapeutics share price is 2.4600 while CATX 8-day exponential moving average is 2.5495, which is a Sell signal.
-
The stock price of CATX is 2.4600 while Perspective Therapeutics 20-day EMA is 2.4438, which makes it a Buy.
-
Perspective Therapeutics 50-day exponential moving average is 2.4987 while CATX share price is 2.4600, making it a Sell technically.
-
CATX stock price is 2.4600 and Perspective Therapeutics 200-day simple moving average is 5.2880, creating a Sell signal.
Fundamental Analysis of Perspective Therapeutics
Is Perspective Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.08 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Perspective Therapeutics
Should I short Perspective Therapeutics stock?
-
CATX Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Perspective Therapeutics is a Buy
-
Perspective Therapeutics Relative Strength Index (RSI) is 51.2, which suggest Perspective Therapeutics is overbought
-
The Bollinger Bands (25) for Perspective Therapeutics is (2.1464 - 2.6064), which suggest Perspective Therapeutics is a Sell
-
The Bollinger Bands (100) for Perspective Therapeutics is (2.1734 - 3.2934), which suggest Perspective Therapeutics is a Sell
* Perspective Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.